Research record: Impact of high-sensitivity next-generation sequencing, measurable residual disease and subsequent stem cell transplant in patients receiving blinatumomab for MRD-positive B-cell acute lymphoblastic leukemia.
Published in Haematologica; first publication date 2026-03-26. PMID 41885010.
This literature update records publication metadata from Europe PMC. Consult the original publication for its methods, findings and limitations.